Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.
Carey-Smith SL, Simad MH, Panchal K, Aya-Bonilla C, Smolders H, Lin S, Armitage JD, Nguyen VT, Bentley K, Ford J, Singh S, Oommen J, Laurent AP, Mercher T, Crispino JD, Montgomery AP, Kassiou M, Besson T, Deau E, Meijer L, Cheung LC, Kotecha RS, Malinge S.
Carey-Smith SL, et al. Among authors: aya bonilla c.
Haematologica. 2024 Jul 1;109(7):2309-2315. doi: 10.3324/haematol.2023.284271.
Haematologica. 2024.
PMID: 38426275
Free PMC article.
No abstract available.